Cynthia D. Jesudason

676 total citations
17 papers, 478 citations indexed

About

Cynthia D. Jesudason is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Cynthia D. Jesudason has authored 17 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Cynthia D. Jesudason's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Pharmacological Effects and Assays (3 papers). Cynthia D. Jesudason is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Pharmacological Effects and Assays (3 papers). Cynthia D. Jesudason collaborates with scholars based in United States, United Kingdom and Australia. Cynthia D. Jesudason's co-authors include Hiroyuki Nakahira, Paul A. Wender, Linda M. Rorick‐Kehn, Rachel I. Anderson, Howard C. Becker, Benjamin L. Adams, Frits C. Stevens, Lawrence J. Slieker, Frank C. Tinsley and Marlene L. Cohen and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

In The Last Decade

Cynthia D. Jesudason

17 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cynthia D. Jesudason United States 10 187 182 116 80 72 17 478
Kentaro Rikimaru Japan 8 103 0.6× 119 0.7× 68 0.6× 58 0.7× 57 0.8× 14 356
Takashi Hashihayata Japan 10 234 1.3× 133 0.7× 83 0.7× 66 0.8× 62 0.9× 18 562
Michael S. Hadley United Kingdom 16 494 2.6× 472 2.6× 118 1.0× 112 1.4× 88 1.2× 55 1.0k
Masahito Abe Japan 12 98 0.5× 168 0.9× 56 0.5× 26 0.3× 40 0.6× 18 358
Yoshinori Sekiguchi Japan 17 277 1.5× 343 1.9× 34 0.3× 134 1.7× 8 0.1× 41 732
Lynn Resnick United States 10 136 0.7× 204 1.1× 13 0.1× 58 0.7× 26 0.4× 16 476
K. Fukatsu Japan 11 241 1.3× 201 1.1× 172 1.5× 279 3.5× 153 2.1× 18 749
Anil Shinde India 14 194 1.0× 197 1.1× 44 0.4× 21 0.3× 23 0.3× 64 507
Garima Chauhan India 13 73 0.4× 82 0.5× 99 0.9× 66 0.8× 51 0.7× 25 395
Megumi Shibahara Japan 8 214 1.1× 200 1.1× 391 3.4× 419 5.2× 227 3.2× 10 811

Countries citing papers authored by Cynthia D. Jesudason

Since Specialization
Citations

This map shows the geographic impact of Cynthia D. Jesudason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia D. Jesudason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia D. Jesudason more than expected).

Fields of papers citing papers by Cynthia D. Jesudason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia D. Jesudason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia D. Jesudason. The network helps show where Cynthia D. Jesudason may publish in the future.

Co-authorship network of co-authors of Cynthia D. Jesudason

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia D. Jesudason. A scholar is included among the top collaborators of Cynthia D. Jesudason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia D. Jesudason. Cynthia D. Jesudason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jesudason, Cynthia D., Peter Bor‐Chian Lin, Audrey Lee‐Gosselin, et al.. (2024). Optimization of SHIP1 Inhibitors for the treatment of Alzheimer’s disease. Alzheimer s & Dementia. 20(S6). 1 indexed citations
2.
Naganawa, Mika, Nabeel Nabulsi, Shannan Henry, et al.. (2020). First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer. Journal of Nuclear Medicine. 62(4). 553–560. 46 indexed citations
3.
Dey, Asim, James S. Bean, Francis S. Willard, et al.. (2020). Selective Phosphodiesterase 1 Inhibitor BTTQ Reduces Blood Pressure in Spontaneously Hypertensive and Dahl Salt Sensitive Rats: Role of Peripheral Vasodilation. Frontiers in Physiology. 11. 543727–543727. 6 indexed citations
4.
Nabulsi, Nabeel, Daniel Holden, Ming‐Qiang Zheng, et al.. (2019). Evaluation of11C-LSN3172176 as a Novel PET Tracer for Imaging M1Muscarinic Acetylcholine Receptors in Nonhuman Primates. Journal of Nuclear Medicine. 60(8). 1147–1153. 16 indexed citations
5.
Paul, Soumen, Mohammad B. Haskali, Jeih-San Liow, et al.. (2018). Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse. Journal of Nuclear Medicine. 60(1). 129–134. 27 indexed citations
6.
Mogg, Adrian J., Thomas E. Eessalu, Megan Johnson, et al.. (2018). In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography. Journal of Pharmacology and Experimental Therapeutics. 365(3). 602–613. 8 indexed citations
7.
Jesudason, Cynthia D., Susan L. DuBois, Megan Johnson, Vanessa Barth, & Anne B. Need. (2017). In Vivo Receptor Occupancy in Rodents by LC-MS/MS. Europe PMC (PubMed Central). 3 indexed citations
8.
Need, Anne B., et al.. (2017). Approaches for the discovery of novel positron emission tomography radiotracers for brain imaging. Clinical and Translational Imaging. 5(3). 265–274. 5 indexed citations
9.
Anderson, Rachel I., Howard C. Becker, Benjamin L. Adams, Cynthia D. Jesudason, & Linda M. Rorick‐Kehn. (2014). Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models. Frontiers in Neuroscience. 8. 33–33. 79 indexed citations
11.
Jesudason, Cynthia D., James E. Baker, Libbey S. O′Farrell, et al.. (2011). Combination of a Beta Adrenoceptor Modulator and a Norepinephrine-Serotonin Uptake Inhibitor for the Treatment of Obesity. ACS Medicinal Chemistry Letters. 2(8). 583–586. 2 indexed citations
12.
Stevens, Frits C., Marlene L. Cohen, Mark L. Heiman, et al.. (2007). Potent oxindole based human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(22). 6270–6273. 43 indexed citations
13.
Bell, Michael G., Marlene L. Cohen, Mark L. Heiman, et al.. (2006). Potent benzimidazolone based human β3-adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(21). 5691–5694. 6 indexed citations
14.
Jesudason, Cynthia D., Lisa S. Beavers, Jeffrey W. Cramer, et al.. (2006). Synthesis and SAR of novel histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(13). 3415–3418. 32 indexed citations
15.
Siegel, Miles G., Cynthia D. Jesudason, John H. McDonald, et al.. (1997). The use of high-throughput synthesis and purification in the preparation of a directed library of adrenergic agents. Molecular Diversity. 3(2). 113–116. 10 indexed citations
16.
Wender, Paul A., et al.. (1997). The First Synthesis of a Daphnane Diterpene:  The Enantiocontrolled Total Synthesis of (+)-Resiniferatoxin. Journal of the American Chemical Society. 119(52). 12976–12977. 155 indexed citations
17.
Baldwin, Jack E., et al.. (1991). The synthesis of substituted aryl diazirines. A bifunctional reagent suitable for application to photoaffinity labelling studies.. Tetrahedron. 47(29). 5603–5614. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026